Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Acq. announced
Inv. presentation
Filed Chapter 11
|
|
Codiak BioSciences, Inc. (CDAK)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/02/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 03/27/2023 |
8-K
| Filed for Chapter 11 |
| 02/14/2023 |
SC 13G/A
| Flagship Ventures Fund V, L.P. reports a 11.8% stake in Codiak BioSciences, Inc. |
| 02/14/2023 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 6.8% stake in CODIAK BIOSCIENCES, INC. |
| 02/09/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2023 |
SC 13G
| Laurion Capital Management LP reports a 5.5% stake in Codiak Biosciences, Inc. |
| 01/26/2023 |
4
| Konstantinov Konstantin (Chief Technology Officer) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 145,000 options to buy
@ $0.74, valued at
$107.3k
|
|
| 01/26/2023 |
4
| Mauro David J (Chief Medical Officer) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 190,000 options to buy
@ $0.74, valued at
$140.6k
|
|
| 01/26/2023 |
4
| Bain Linda (CFO) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 185,000 options to buy
@ $0.74, valued at
$136.9k
|
|
| 01/26/2023 |
4
| Howze Yalonda (See Remarks) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 150,000 options to buy
@ $0.74, valued at
$111k
|
|
| 01/26/2023 |
4
| Sathyanarayanan Sriram (Chief Scientific Officer) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 140,000 options to buy
@ $0.74, valued at
$103.6k
|
|
| 01/26/2023 |
4
| Barna Nicole (See Remarks) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 105,000 options to buy
@ $0.74, valued at
$77.7k
|
|
| 01/26/2023 |
4
| WILLIAMS DOUGLAS E (President & CEO) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 465,000 options to buy
@ $0.74, valued at
$344.1k
|
|
| 01/23/2023 |
4
| Bain Linda (CFO) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Sold 1,880 shares
@ $0.575, valued at
$1.1k
Exercised 5,000 restricted stock units
@ $0 |
|
| 01/23/2023 |
4
| Konstantinov Konstantin (Chief Technology Officer) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Sold 1,069 shares
@ $0.5752, valued at
$614.9
Exercised 2,800 restricted stock units
@ $0 |
|
| 01/23/2023 |
4
| Sathyanarayanan Sriram (Chief Scientific Officer) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Sold 1,082 shares
@ $0.5751, valued at
$622.3
Exercised 2,834 restricted stock units
@ $0 |
|
| 01/23/2023 |
4
| WILLIAMS DOUGLAS E (See Remarks) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Sold 5,075 shares
@ $0.575, valued at
$2.9k
Exercised 13,667 restricted stock units
@ $0 |
|
| 01/23/2023 |
4
| Howze Yalonda (See Remarks) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Sold 1,512 shares
@ $0.5752, valued at
$869.7
Exercised 4,000 restricted stock units
@ $0 |
|
| 01/23/2023 |
4
| Barna Nicole (See Remarks) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Sold 836 shares
@ $0.575, valued at
$480.7
Exercised 2,167 restricted stock units
@ $0 |
|
| 11/03/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/03/2022 |
8-K
| Quarterly results |
| 09/20/2022 |
SC 13D
| ARCH Venture Fund VIII, L.P. reports a 24.7% stake in Codiak Biosciences, Inc. |
| 09/20/2022 |
4
| Sathyanarayanan Sriram (Chief Scientific Officer) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 80,000 restricted stock units
@ $0 |
|
| 09/20/2022 |
4
| Bain Linda (CFO) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 80,000 restricted stock units
@ $0 |
|
| 09/20/2022 |
4
| Mauro David J (Chief Medical Officer) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 80,000 restricted stock units
@ $0 |
|
| 09/20/2022 |
4
| Konstantinov Konstantin (Chief Technology Officer) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 80,000 restricted stock units
@ $0 |
|
| 09/20/2022 |
4
| Barna Nicole (See Remarks) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 80,000 restricted stock units
@ $0 |
|
| 09/20/2022 |
4
| Howze Yalonda (See Remarks) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 80,000 restricted stock units
@ $0 |
|
| 09/16/2022 |
4
| Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Bought 722,590 shares
@ $0
Bought 210,743 shares
@ $0
Bought 722,590 options to buy
@ $1.875, valued at
$1.4M
Bought 210,743 options to buy
@ $1.875, valued at
$395.1k
|
|
| 09/15/2022 |
4
| GILLIS STEVEN (Director) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Bought 5,000,000 shares
@ $0
Bought 5,000,000 warrants
@ $1.875, valued at
$9.4M
|
|
| 09/15/2022 |
4
| ARCH Venture Fund VIII, L.P. (10% Owner) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Bought 5,000,000 shares
@ $1.5, valued at
$7.5M
Bought 5,000,000 warrants
@ $1.875, valued at
$9.4M
|
|
| 09/12/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 08/30/2022 |
8-K
| Cost Associated with Exit or Disposal Activities, Other Events, Financial Statements and Exhibits Interactiv... |
| 08/04/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
|
|
|